Mar 20, 2020
North America's Tumor Ablation Market by Treatment, Technology, Application and Country - Forecast to 2025
Mar 19, 2020
Positive Results from Registrational Study of LENVIMA® (lenvatinib) and KEYTRUDA® (pembrolizumab) in Advanced Endometrial Carcinoma Published in the Journal of Clinical Oncology
Mar 10, 2020
First Liver Cancer Patient Dosed in the MIV-818 Phase Ib Study
Mar 05, 2020
Zydus Announces World's First Drug for the Treatment of Non-Cirrhotic NASH
Feb 19, 2020
ChemomAb Ltd. Announces Issuance of Composition of Matter Patent for CM-101 and Reinforces its IP Portfolio
Feb 17, 2020
Ascletis' IND Filing for Its Non-alcoholic Steatohepatitis (NASH) Drug Accepted by NMPA
Feb 15, 2020
Eisai Announces Latest Data for LENVIMA® (lenvatinib) in Combination with Everolimus for Advanced Non-Clear Cell Renal Cell Carcinoma
Feb 13, 2020
Medivir AB: Year End Report January-December 2019
Feb 10, 2020
Eisai to Present Latest on LENVIMA® (lenvatinib) at the 2020 Genitourinary Cancers Symposium
Jan 28, 2020
The Global Bilirubin Blood Test Market is expected to grow by USD 562.5 mn during 2020-2024, progressing at a CAGR of 8% during the forecast period
Jan 28, 2020
Enzychem Lifesciences Appoints Dr. Michael Charlton To Its Scientific Advisory Board
Jan 22, 2020
Metacrine Demonstrates Best-in-Class FXR Drug Program with Positive Clinical Results in NASH Patients
Jan 17, 2020
Latest IDEXX Innovations Designed to Enhance Patient Care and Drive Veterinary Productivity
Jan 13, 2020
Akero Therapeutics Expands Phase 2a Trial in NASH to Include Cohort of Cirrhotic Patients
Jan 07, 2020
The Assistance Fund Opens New Program for Pompe Disease
Jan 06, 2020
Protagonist Therapeutics Initiates Phase 2 Study of Novel Hepcidin Mimetic PTG-300 in the Treatment of Patients with Hereditary Hemochromatosis
Jan 06, 2020
CStone Pharmaceuticals and Blueprint Medicines Initiate Phase 1b/2 Clinical Trial of Fisogatinib in Combination with CS1001 for Patients with Hepatocellular Carcinoma
Dec 03, 2019
Protagonist Therapeutics Announces Preliminary Phase 2 Results with Hepcidin Mimetic PTG-300 in the Treatment of Transfusion Dependent Beta-Thalassemia
Nov 18, 2019
Medivir Reports Last Patient Recruited to the Phase Ia Study of MIV-818 in Liver Cancer Patients and Initial Dose Determined for phase Ib
Nov 12, 2019
Laboratory for Advanced Medicine Presents New Liver Cancer Test Data at The Liver Meeting 2019